Jitti Hanprasertpong
Overview
Explore the profile of Jitti Hanprasertpong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leetanaporn K, Hanprasertpong J
Int J Gynecol Cancer
. 2025 Feb;
:101633.
PMID: 39955190
Objective: We evaluated the effectiveness of chemoradiation compared with radiotherapy alone in older patients with cervical cancer and determined the age sub-group wherein chemotherapy loses its significance using the Surveillance,...
2.
Molika P, Leetanaporn K, Rungkamoltip P, Roytrakul S, Hanprasertpong J, Navakanitworakul R
Transl Cancer Res
. 2023 Dec;
12(11):3113-3128.
PMID: 38130315
Background: Cervical cancer (CC) is the fourth most common cancer in females worldwide. Existing biomarkers for CC, such as squamous cell carcinoma antigens, show low specificity. Hence, a novel biomarker...
3.
Molika P, Bissanum R, Surachat K, Pattanapanyasat K, Hanprasertpong J, Chotigeat W, et al.
Oncology
. 2023 Aug;
102(1):53-66.
PMID: 37573780
Introduction: Cervical cancer (CC) is the fourth most common cancer type and a leading cause of cancer-related deaths in women worldwide. Its underlying molecular mechanisms are unclear. Cancer cell-derived extracellular...
4.
Dhanaworavibul K, Leetanaporn K, Wattanapaisal P, Deevongkij K, Leelarujijaroen C, Hanprasertpong J
Oncol Res Treat
. 2023 Mar;
46(5):192-200.
PMID: 36878195
Introduction: A few studies have explored the association of resting heart rate (RHR) with mortality and/or other oncological outcomes in patients with specific cancers such as breast, colorectal, and lung...
5.
Atjimakul T, Hanprasertpong J
Obstet Gynecol Int
. 2022 Sep;
2022:3446293.
PMID: 36124140
Background: Bone recurrence occurs in 0.75%-8% of cervical cancer patients after primary treatment. Only a few previous studies have reported on survival times associated with prognostic factors for bone recurrent...
6.
Atjimakul T, Wattanapaisal P, Suwiwat S, Wanichsuwan W, Hanprasertpong J
J Obstet Gynaecol
. 2022 Aug;
42(7):3117-3123.
PMID: 35930016
Here, we determined the frequency of microsatellite instability (MSI) and the impact of MSI-high (MSI-H) on clinical outcomes of Thai patients with endometrial cancer (EC). Tissue samples of 110 Thai...
7.
Leetanaporn K, Hanprasertpong J
Cancer Manag Res
. 2022 Jun;
14:1961-1972.
PMID: 35726336
Purpose: The oncological outcomes of locally advanced cervical cancer (LACC) patients after treatment are poor and heterogeneous. This study aimed to determine the role of the hemoglobin-albumin-lymphocyte-platelet (HALP) inflammatory index...
8.
Tangkananan A, Thongkhao P, Janmunee N, Hanprasertpong J
J Med Imaging Radiat Oncol
. 2022 Jun;
66(7):1014-1021.
PMID: 35695633
Introduction: To investigate the association between chemotherapy (CMT) cycles and oncological outcomes in elders with locally advanced cervical cancer (LACC) who treated with concurrent chemoradiotherapy (CCRT). Methods: We retrospective studied...
9.
Leetanaporn K, Hanprasertpong J, Navakanitworakul R
Oncol Rev
. 2021 Oct;
15(2):542.
PMID: 34667488
Cell-to-cell communication is a pivotal aspect of cancer biology. Recently, extracellular vesicles (EVs)have been shown to play essential roles in intercellular communications between cancer cells and the surrounding microenvironment owing...
10.
Theplib A, Hanprasertpong J, Leetanaporn K
Biomed Res Int
. 2020 Dec;
2020:5791381.
PMID: 33274215
Objective: To identify the incidence of ovarian metastasis and the impact of ovarian preservation on oncological outcomes for early-stage adenocarcinoma and adenosquamous cervical cancer. Methods: 281 patients with stages IA2-IB1...